Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.
Published October 22, 2025 · Recall initiated: October 6, 2025
Summary
FDA records drug Class II recall D-0016-2026, published October 22, 2025 and initiated October 6, 2025. Recalling firm: VIONA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 13080 bottles; Lot: Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration
What to do
Voluntary: Firm initiated · Letter
Get an email if TAVABOROLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TAVABOROLE
- Manufacturer
- VIONA PHARMACEUTICALS INC
- Distributor
- USA Nationwide
- Lot
- Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose CompoundingOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottleOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDCOctober 22, 2025
- FDAPERIFIX FX Continuous Epidural Anesthesia Tray with PERIFIX 17 Ga. x 3-1/2 in. (8.9 cm) Tuohy Epidural NeedleOctober 15, 2025
- FDAAW Server 2.0, AW Server 3.0, AW Server 3.1, AW Server 3.2October 15, 2025
- FDATavaborole Topical Solution 5%, 10 mL per glass bottle, Rx Only, For Topical Use Only, Manufactured by: ZydusAugust 27, 2025
Questions about this recall
Was Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04. recalled?
Yes. FDA published recall D-0016-2026 on October 22, 2025. Reported hazard: Discoloration
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TAVABOROLE.